Darzalex – Daratumumab uses, dose and side effects
DARZALEX is a cancer medicine that contains the active substance daratumumab. It belongs to a group of drugs called monoclonal antibodies. Monoclonal antibodies are proteins that have been designed to recognize and attach to specific targets in the body. Daratumumab is designed to attach to specific cancer cells in your body so that the immune system can destroy the cancer cells.
Read More